In June 2022, Tel-Array added Japan to its list of national patents granted on the Spot Profiler multiplex immunoassay platform. Other countries that have granted patents on the Spot Profiler are the USA and Australia; both these patents were granted in late 2021. Patents from 7 other jurisdictions are currently in the national examination phase and are expected to be granted throughout 2022-2023.